<?xml version='1.0' encoding='utf-8'?>
<document id="22752008"><sentence text="In vitro characterization of the drug-drug interaction potential of catabolites of antibody-maytansinoid conjugates." /><sentence text="The in vitro characterization of the inhibition potential of four representative maytansinoid species observed upon hepatic and/or tumor in vivo processing of antibody-maytansine conjugates (AMCs) with cleavable and noncleavable linkers is reported" /><sentence text=" We investigated the free maytansinoid species N(2')-deacetyl-N(2')-(3-mercapto-1-oxopropyl)-maytansine (DM1), (S)-methyl-DM1, and N(2')-deacetyl-N(2')-(4-mercapto-4-methyl-1-oxopentyl)-maytansine (DM4) as representative cleavable linker catabolites and Lysine-N(ε)-N-succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate-DM1 (Lys-MCC-DM1) as the representative noncleavable linker catabolite"><entity charOffset="47-103" id="DDI-PubMed.22752008.s3.e0" text="N(2')-deacetyl-N(2')-(3-mercapto-1-oxopropyl)-maytansine" /><entity charOffset="105-108" id="DDI-PubMed.22752008.s3.e1" text="DM1" /><entity charOffset="111-125" id="DDI-PubMed.22752008.s3.e2" text="(S)-methyl-DM1" /><entity charOffset="131-196" id="DDI-PubMed.22752008.s3.e3" text="N(2')-deacetyl-N(2')-(4-mercapto-4-methyl-1-oxopentyl)-maytansine" /><entity charOffset="198-201" id="DDI-PubMed.22752008.s3.e4" text="DM4" /><entity charOffset="254-332" id="DDI-PubMed.22752008.s3.e5" text="Lysine-N(ε)-N-succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate-DM1" /><entity charOffset="122-199" id="DDI-PubMed.22752008.s3.e6" text="DM1" /><entity charOffset="329-406" id="DDI-PubMed.22752008.s3.e7" text="DM1" /><entity charOffset="342-419" id="DDI-PubMed.22752008.s3.e8" text="DM1" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e0" e2="DDI-PubMed.22752008.s3.e0" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e0" e2="DDI-PubMed.22752008.s3.e1" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e0" e2="DDI-PubMed.22752008.s3.e2" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e0" e2="DDI-PubMed.22752008.s3.e6" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e0" e2="DDI-PubMed.22752008.s3.e3" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e0" e2="DDI-PubMed.22752008.s3.e4" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e0" e2="DDI-PubMed.22752008.s3.e5" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e0" e2="DDI-PubMed.22752008.s3.e7" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e0" e2="DDI-PubMed.22752008.s3.e8" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e1" e2="DDI-PubMed.22752008.s3.e1" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e1" e2="DDI-PubMed.22752008.s3.e2" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e1" e2="DDI-PubMed.22752008.s3.e6" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e1" e2="DDI-PubMed.22752008.s3.e3" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e1" e2="DDI-PubMed.22752008.s3.e4" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e1" e2="DDI-PubMed.22752008.s3.e5" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e1" e2="DDI-PubMed.22752008.s3.e7" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e1" e2="DDI-PubMed.22752008.s3.e8" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e2" e2="DDI-PubMed.22752008.s3.e2" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e2" e2="DDI-PubMed.22752008.s3.e6" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e2" e2="DDI-PubMed.22752008.s3.e3" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e2" e2="DDI-PubMed.22752008.s3.e4" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e2" e2="DDI-PubMed.22752008.s3.e5" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e2" e2="DDI-PubMed.22752008.s3.e7" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e2" e2="DDI-PubMed.22752008.s3.e8" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e6" e2="DDI-PubMed.22752008.s3.e6" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e6" e2="DDI-PubMed.22752008.s3.e3" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e6" e2="DDI-PubMed.22752008.s3.e4" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e6" e2="DDI-PubMed.22752008.s3.e5" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e6" e2="DDI-PubMed.22752008.s3.e7" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e6" e2="DDI-PubMed.22752008.s3.e8" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e3" e2="DDI-PubMed.22752008.s3.e3" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e3" e2="DDI-PubMed.22752008.s3.e4" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e3" e2="DDI-PubMed.22752008.s3.e5" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e3" e2="DDI-PubMed.22752008.s3.e7" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e3" e2="DDI-PubMed.22752008.s3.e8" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e4" e2="DDI-PubMed.22752008.s3.e4" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e4" e2="DDI-PubMed.22752008.s3.e5" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e4" e2="DDI-PubMed.22752008.s3.e7" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e4" e2="DDI-PubMed.22752008.s3.e8" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e5" e2="DDI-PubMed.22752008.s3.e5" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e5" e2="DDI-PubMed.22752008.s3.e7" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e5" e2="DDI-PubMed.22752008.s3.e8" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e7" e2="DDI-PubMed.22752008.s3.e7" /><pair ddi="false" e1="DDI-PubMed.22752008.s3.e7" e2="DDI-PubMed.22752008.s3.e8" /></sentence><sentence text=" Studies with recombinant human cytochromes P450 (P450s) indicate CYP2D6, CYP3A4, and CYP3A5 are the primary isoforms responsible for the oxidative metabolism of DM1, (S)-methyl-DM1, and DM4"><entity charOffset="162-164" id="DDI-PubMed.22752008.s4.e0" text="DM1" /><entity charOffset="178-180" id="DDI-PubMed.22752008.s4.e1" text="DM1" /><entity charOffset="187-189" id="DDI-PubMed.22752008.s4.e2" text="DM4" /><pair ddi="false" e1="DDI-PubMed.22752008.s4.e0" e2="DDI-PubMed.22752008.s4.e0" /><pair ddi="false" e1="DDI-PubMed.22752008.s4.e0" e2="DDI-PubMed.22752008.s4.e1" /><pair ddi="false" e1="DDI-PubMed.22752008.s4.e0" e2="DDI-PubMed.22752008.s4.e2" /><pair ddi="false" e1="DDI-PubMed.22752008.s4.e1" e2="DDI-PubMed.22752008.s4.e1" /><pair ddi="false" e1="DDI-PubMed.22752008.s4.e1" e2="DDI-PubMed.22752008.s4.e2" /></sentence><sentence text=" Lys-MCC-DM1 was not metabolized by any of the P450 isoforms studied"><entity charOffset="9-11" id="DDI-PubMed.22752008.s5.e0" text="DM1" /></sentence><sentence text=" DM1 was shown to be a reversible inhibitor of CYP2C8 (K(i) = 11 ± 3 μM) and CYP2D6 (K(i) = 14 ± 2 μM)"><entity charOffset="1-3" id="DDI-PubMed.22752008.s6.e0" text="DM1" /></sentence><sentence text=" Lys-MCC-DM1 and (S)-methyl-DM1 showed no reversible or time-dependent inactivation of any of the P450s studied"><entity charOffset="17-31" id="DDI-PubMed.22752008.s7.e0" text="(S)-methyl-DM1" /><entity charOffset="9-22" id="DDI-PubMed.22752008.s7.e1" text="DM1" /><entity charOffset="28-41" id="DDI-PubMed.22752008.s7.e2" text="DM1" /><pair ddi="false" e1="DDI-PubMed.22752008.s7.e1" e2="DDI-PubMed.22752008.s7.e1" /><pair ddi="false" e1="DDI-PubMed.22752008.s7.e1" e2="DDI-PubMed.22752008.s7.e0" /><pair ddi="false" e1="DDI-PubMed.22752008.s7.e1" e2="DDI-PubMed.22752008.s7.e2" /><pair ddi="false" e1="DDI-PubMed.22752008.s7.e0" e2="DDI-PubMed.22752008.s7.e0" /><pair ddi="false" e1="DDI-PubMed.22752008.s7.e0" e2="DDI-PubMed.22752008.s7.e2" /></sentence><sentence text=" DM1 and DM4 inactivated CYP3A from human liver microsomes with K(i)/k(inact) values of 4"><entity charOffset="1-3" id="DDI-PubMed.22752008.s8.e0" text="DM1" /><entity charOffset="9-11" id="DDI-PubMed.22752008.s8.e1" text="DM4" /><pair ddi="false" e1="DDI-PubMed.22752008.s8.e0" e2="DDI-PubMed.22752008.s8.e0" /><pair ddi="false" e1="DDI-PubMed.22752008.s8.e0" e2="DDI-PubMed.22752008.s8.e1" /></sentence><sentence text="8 ± 0" /><sentence text="9 μM/0" /><sentence text="035 ± 0" /><sentence text="002 min(-1) and 3" /><sentence text="3 ± 0" /><sentence text="2 μM/0" /><sentence text="114 ± 0" /><sentence text="002 min(-1), respectively" /><sentence text=" DM1 and DM4 inactivated recombinant CYP3A4 with K(i)/k(inact) values of 3"><entity charOffset="1-3" id="DDI-PubMed.22752008.s17.e0" text="DM1" /><entity charOffset="9-11" id="DDI-PubMed.22752008.s17.e1" text="DM4" /><pair ddi="false" e1="DDI-PubMed.22752008.s17.e0" e2="DDI-PubMed.22752008.s17.e0" /><pair ddi="false" e1="DDI-PubMed.22752008.s17.e0" e2="DDI-PubMed.22752008.s17.e1" /></sentence><sentence text="4 ± 1" /><sentence text="0 μM/0" /><sentence text="058 ± 0" /><sentence text="005 min(-1) and 1" /><sentence text="4 ± 0" /><sentence text="3 μM/0" /><sentence text="117 ± 0" /><sentence text="006 min(-1), respectively" /><sentence text=" Because of instability in plasma, further characterization of the DM1 and DM4 intramolecular and intermolecular disulfide conjugates observed in vivo is required before an accurate drug-drug interaction (DDI) prediction can be made"><entity charOffset="113-122" id="DDI-PubMed.22752008.s26.e0" text="disulfide" /><entity charOffset="67-75" id="DDI-PubMed.22752008.s26.e1" text="DM1" /><entity charOffset="75-83" id="DDI-PubMed.22752008.s26.e2" text="DM4" /><pair ddi="false" e1="DDI-PubMed.22752008.s26.e1" e2="DDI-PubMed.22752008.s26.e1" /><pair ddi="false" e1="DDI-PubMed.22752008.s26.e1" e2="DDI-PubMed.22752008.s26.e2" /><pair ddi="false" e1="DDI-PubMed.22752008.s26.e1" e2="DDI-PubMed.22752008.s26.e0" /><pair ddi="false" e1="DDI-PubMed.22752008.s26.e2" e2="DDI-PubMed.22752008.s26.e2" /><pair ddi="false" e1="DDI-PubMed.22752008.s26.e2" e2="DDI-PubMed.22752008.s26.e0" /></sentence><sentence text=" AMCs with noncleavable thioether-linked DM1 as the cytotoxic agent are predicted to have no potential for a DDI with any of the major human P450s studied"><entity charOffset="41-43" id="DDI-PubMed.22752008.s27.e0" text="DM1" /></sentence><sentence text="" /></document>